Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOFT
NCT00066690Phase 3Completed
- Sponsor
- ETOP IBCSG Partners Foundation
- Start
- Dec 2003
- Primary completion
- May 2014
- Modality
- Peptides, Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of exemestane, triptorelin in breast cancer, sponsored by ETOP IBCSG Partners Foundation. Started Dec 2003; status: completed.
02
Drugs
exemestanetriptorelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00066690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00066690.